Skip to content
  • Sunday, 26 July 2026
  • 3:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
Laboratory Automation & Robotics

EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform

Lana Keisha Jun 29, 2026 0

The intricate world of pharmaceutical research, particularly the demanding phases of clinical trials, stands at a pivotal juncture. Faced with…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 29, 2026 0

In a comprehensive clinical update presented on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, alongside host Vincent…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 28, 2026 0

In a stark assessment of the current state of public health in the United States, Dr. Daniel Griffin and Vincent…

Read More
Stem Cell & Regenerative Medicine

Study Reveals Explosive Growth Rates of Chronic Myeloid Leukemia Years Before Clinical Diagnosis and Identifies Factors Influencing Treatment Response

Dwi Wanna Jun 24, 2026 0

Chronic myeloid leukemia (CML), a malignancy of the white blood cells characterized by the presence of the Philadelphia chromosome, has…

Read More
Pharmaceutical R&D

The Crucial Role of Data Reliability in Early-Phase Clinical Trials for Pharmaceutical Development

Teuku Ryan Jun 23, 2026 0

In the intricate landscape of pharmaceutical research and development, the integrity of data generated during early-phase clinical trials serves as…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 23, 2026 0

In a post-New Year’s Eve recording, Dr. Daniel Griffin and Vincent Racaniello of "This Week in Virology" (TWiV) offered a…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Public Health Data

Lina Irawan Jun 22, 2026 0

In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…

Read More
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Vaccine Policy and Ongoing Public Health Challenges

Lina Irawan Jun 22, 2026 0

In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound concern…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 21, 2026 0

In a comprehensive clinical update shared on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, a seasoned clinician…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 21, 2026 0

In a stark assessment of the current state of public health in the United States, Dr. Daniel Griffin, a seasoned…

Read More

Posts pagination

1 2 3 4 … 25
The Subtle Art of Cellular Division: How Different Failures Lead to Drastically Different OutcomesFDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study DesignInsilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ